Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.
Market analyst Prakash Gaba has suggested four BUY Calls today and no SELL calls.
Market analyst Ashwani Gujral has suggested two BUY Calls and three SELL calls for today’s trading session.
Technical analyst Sudarshan Sukhani has suggested three BUY calls and one SELL call for today’s session, suggesting bullish sentiment.
Technical analyst Sudarshan Sukhani has two stocks on his selling list and two on his buying list for the traders today.
Epic Research recommends three stocks for investors....
